# Otsuka Pharmaceutical Co., Ltd. – FDA Inspection, Oct 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-co-ltd/f30fa95f-343e-421f-b13a-4b04ac8cc11a
Source feed: FDA_Inspections

> FDA inspection 1107691 of Otsuka Pharmaceutical Co., Ltd., October 22, 2019. Classification: Voluntary Action Indicated (VAI). 7 citations under 21 CFR part 211. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107691
- Company Name: Otsuka Pharmaceutical Co., Ltd.
- Inspection Date: 2019-10-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 7

## Related Documents

- [FDA Inspection 1265342 - 2025-06-17](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-co-ltd/cd62a295-51a7-49ae-b140-a2c0ef894119)
- FDA Inspection 994655 - 2016-09-22
- [FDA Inspection 887144 - 2014-06-17](https://www.keypedia.com/records/fda_inspections/otsuka-pharmaceutical-co-ltd/c4dc4524-e56e-4104-89e2-d0de9ff9cda4)
- FDA Inspection 793343 - 2012-07-19

Company: https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/4106c23b-a243-4485-8ab6-a3dd8a7258ad

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
